A new approach to managing the Covid-19 pandemic now could be on the table: antiviral pills. On Friday, Merck and Ridgeback Biotherapeutics said their results (still not peer-reviewed) demonstrate their novel drug molnupiravir cut in half the rate of hospitalization and death in persons with mild to moderate disease. If authorized by the US Food and Drug Administration for emergency use, the pill would become the first oral medicine to fight viral infection for Covid-19.
http://dlvr.it/S8pX2V
Comments
Post a Comment